| Product Code: ETC10535973 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Ankylosing Spondylitis Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Ankylosing Spondylitis Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Ankylosing Spondylitis Market - Industry Life Cycle |
3.4 Greece Ankylosing Spondylitis Market - Porter's Five Forces |
3.5 Greece Ankylosing Spondylitis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Greece Ankylosing Spondylitis Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Greece Ankylosing Spondylitis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Greece Ankylosing Spondylitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about ankylosing spondylitis among healthcare professionals and patients in Greece |
4.2.2 Growing research and development activities for new treatment options |
4.2.3 Rising prevalence of ankylosing spondylitis in the Greek population |
4.3 Market Restraints |
4.3.1 Limited access to advanced treatments and therapies in Greece |
4.3.2 Stringent regulatory requirements for approval of new medications |
4.3.3 High cost associated with ankylosing spondylitis treatment in Greece |
5 Greece Ankylosing Spondylitis Market Trends |
6 Greece Ankylosing Spondylitis Market, By Types |
6.1 Greece Ankylosing Spondylitis Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Greece Ankylosing Spondylitis Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Greece Ankylosing Spondylitis Market Revenues & Volume, By NSAIDs, 2021 - 2031F |
6.1.4 Greece Ankylosing Spondylitis Market Revenues & Volume, By Biologic Drugs, 2021 - 2031F |
6.1.5 Greece Ankylosing Spondylitis Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.1.6 Greece Ankylosing Spondylitis Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.2 Greece Ankylosing Spondylitis Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Greece Ankylosing Spondylitis Market Revenues & Volume, By Pain & Inflammation, 2021 - 2031F |
6.2.3 Greece Ankylosing Spondylitis Market Revenues & Volume, By Disease Management, 2021 - 2031F |
6.2.4 Greece Ankylosing Spondylitis Market Revenues & Volume, By Mobility Improvement, 2021 - 2031F |
6.2.5 Greece Ankylosing Spondylitis Market Revenues & Volume, By Severe Cases Treatment, 2021 - 2031F |
6.3 Greece Ankylosing Spondylitis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Greece Ankylosing Spondylitis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Greece Ankylosing Spondylitis Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Greece Ankylosing Spondylitis Market Revenues & Volume, By Rehabilitation Centers, 2021 - 2031F |
6.3.5 Greece Ankylosing Spondylitis Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
7 Greece Ankylosing Spondylitis Market Import-Export Trade Statistics |
7.1 Greece Ankylosing Spondylitis Market Export to Major Countries |
7.2 Greece Ankylosing Spondylitis Market Imports from Major Countries |
8 Greece Ankylosing Spondylitis Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of ankylosing spondylitis |
8.2 Percentage of patients receiving biologic therapies |
8.3 Patient-reported outcomes improvement rate |
8.4 Number of clinical trials for ankylosing spondylitis conducted in Greece |
8.5 Rate of adherence to treatment guidelines among healthcare providers |
9 Greece Ankylosing Spondylitis Market - Opportunity Assessment |
9.1 Greece Ankylosing Spondylitis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Greece Ankylosing Spondylitis Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Greece Ankylosing Spondylitis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Greece Ankylosing Spondylitis Market - Competitive Landscape |
10.1 Greece Ankylosing Spondylitis Market Revenue Share, By Companies, 2024 |
10.2 Greece Ankylosing Spondylitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |